Clinical Trial Update: Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Curosurf in invasively ventilated infants under 12 months with severe viral bronchiolitis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Viral

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Bronchiolitis, Viral | Phase 3 | Status: TERMINATED